Antibe Therapeutics Inc(Pre-Merger) T.ATE

Primary Symbol: ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Never forget

<< Previous

Bullboard Posts

Next >>

Comment by Inthepezon Oct 03, 2021 7:51am

108 Views

Post# 33958425

RE:Never forget

Close ratface, but that was directed at Duster. See how you don’t pay attention at all. Lmao!!

Rarbar99 wrote: On June 17, when ATE was at $4 CAD, InThePez famously said to Yukon: "You missed the point fud fairy. I’m not forecasting. Don’t get caught with your pants down like with the nuance deal."

Looks like Pez was the one who was caught with his pants down. He went on to say how Ate should be above $10 and the $4 entry is too low (I'm not joking, look at his profile and read it yourself, these comments were posted in June 15-June 20, just a month before the crash.

<< Previous

Bullboard Posts

Next >>

Canadian rare earths stock up as drilling starts at uranium property